GSK-2798745

N/A

Report date: 2024/11/09 20:00:08
NME

Base Information

Drug NameGSK-2798745
Drug Alias NameGSK-2798745
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 4 antagonists
TargetsTransient receptor potential cation channel subfamily V member 4
Therapy Area/IndicationsHeart FailureMacular EdemaCough
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHeart FailureMacular EdemaCough

Other Information

ATC CodeN/A
Related LinksN/A